Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06479174 · ClinicalTrials.gov registry record · NA

Cognitive Strategies for Optimizing Brain Health And Managing Transgenerational Vascular Risk Factors Post-Stroke

A NA study of Stroke, Ischemic, sponsored by University of New Mexi.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06479174: Recruiting NA study of Stroke, Ischemic, sponsored by University of New Mexi.

NCT06479174 is a NA study of Stroke, Ischemic that is actively recruiting participants, run by University of New Mexi. The registered enrollment target is 40 participants, below the 288-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06479174, a NA study of Stroke, Ischemic, is actively recruiting participants, sponsored by University of New Mexi.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

People living with the cognitive effects of stroke are at risk for recurrent stroke and further cognitive decline. Also problematic is that stroke risk clusters in families and biological family members of people who have ischemic stroke may also be at increased risk of stroke and/or cognitive decline. The primary goal of this study is to test the feasibility of a virtually delivered cognitive strategy training and health coaching program to reduce vascular risk and promote brain health in persons with stroke and their biological family members.

Primary Outcome

metric scores for vascular risk; score is calculated on a 0-100 scale where 100 is ideal

Conditions Studied

Interventions

  • BEHAVIORAL CHAMPS-TR

Study Locations (1)

New Mexico

  • University of New Mexico Health Sciences Center - Albuquerque

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-10-12
Est. Completion 2026-06-30
Phase NA
University of New Mexi

76 total trials

What NCT06479174 shows while recruiting

NCT06479174 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 288-participant average among 33 other Stroke, Ischemic trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Stroke, Ischemic appearing as the primary indexed condition, and to 1 intervention - of which CHAMPS-TR is the first listed.

NCT06479174 reports a single indexed study location in New Mexico.

Frequently Asked Questions

What is clinical trial NCT06479174 about?

NCT06479174 is a clinical study titled "Cognitive Strategies for Optimizing Brain Health And Managing Transgenerational Vascular Risk Factors Post-Stroke". People living with the cognitive effects of stroke are at risk for recurrent stroke and further cognitive decline. Also problematic is that stroke risk clusters in families and biological family members of people who have ischemic stroke may also be at increased risk of stroke and/or cognitive decli...

What is the current status of trial NCT06479174?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-10-12. Estimated completion is 2026-06-30.

What conditions does trial NCT06479174 study?

This clinical trial studies the following conditions: Stroke, Ischemic.

What interventions are being tested in trial NCT06479174?

The interventions under investigation include: CHAMPS-TR (BEHAVIORAL).

Who is sponsoring clinical trial NCT06479174?

This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06479174 being conducted?

This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke, Ischemic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06479174's enrollment target sits among peer trials

40 24th of 33 higher than 9 of 33 other Stroke, Ischemic trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke, Ischemic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06479174, the US trial registry maintained by the National Library of Medicine. NCT06479174 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.